SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-21-007501
Filing Date
2021-05-18
Accepted
2021-05-18 16:37:12
Documents
9
Period of Report
2021-07-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A nviv-20210716xdef14a.htm DEF 14A 873054
2 GRAPHIC nviv-20210716xdef14a018.jpg GRAPHIC 118188
3 GRAPHIC nviv-20210716xdef14a016.jpg GRAPHIC 137181
4 GRAPHIC nviv-20210716xdef14a019.jpg GRAPHIC 122901
5 GRAPHIC nviv-20210716xdef14a014.jpg GRAPHIC 141141
6 GRAPHIC nviv-20210716xdef14a015.jpg GRAPHIC 105859
7 GRAPHIC nviv-20210716xdef14a001.jpg GRAPHIC 4398
8 GRAPHIC nviv-20210716xdef14a002.jpg GRAPHIC 4283
9 GRAPHIC nviv-20210716xdef14a017.jpg GRAPHIC 100038
  Complete submission text file 0001558370-21-007501.txt   1886175
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37350 | Film No.: 21936590
SIC: 3841 Surgical & Medical Instruments & Apparatus